Sterile Medical Wound Dressing Manufacturing

The contract calls for the manufacture of sterile, silver-coated antimicrobial surgical wound dressings measuring 6x6 inches, designed with absorbent properties and a non-woven elastomeric polyurethane adhesive backing to ensure secure application and patient comfort. These dressings are intended for use in surgical settings where infection control is critical, leveraging the antimicrobial properties of silver to reduce the risk of wound contamination and promote healing. The product must meet strict sterility standards and performance specifications to ensure reliability in high-demand medical environments. This is a subcontract under the Department of Defense’s Medical Supply Chain, specifically managed by the MEDICAL SUPPLY CHAIN MD SURG FSF, with performance focused at Fort Bragg, North Carolina, ZIP 28310. The solicitation was posted on July 23, 2026, with a response deadline of July 29, 2026, indicating a rapid procurement timeline. The NAICS code 325120 identifies this as a pharmaceutical and medicine manufacturing activity, aligning with the specialized nature of the product. The contract is issued through the DLA DIBBS system, signaling its placement within the broader defense logistics framework for critical medical supplies.